
As of March 2025, psychedelic mushrooms are illegal in Michigan. However, there is a growing movement to decriminalize them, with cities like Detroit, Ann Arbor, and Hazel Park leading the way. Decriminalization means that while psilocybin remains illegal, law enforcement deprioritizes arrests and prosecutions for possession or personal use. Proponents of decriminalization cite the medical benefits of psilocybin mushrooms in treating addictions, depression, and other mental health disorders. While federal law still prohibits psilocybin possession and therapeutic use, the changing landscape of psychedelic reform in Michigan and nationwide indicates a potential shift in attitudes and legislation regarding these substances.
| Characteristics | Values |
|---|---|
| Legal status of psychedelic mushrooms in Michigan | As of March 2025, psychedelic mushrooms are illegal in Michigan and classified as a Schedule I controlled substance under state law. However, some cities in Michigan, including Detroit, Ann Arbor, and Hazel Park, have decriminalized their use, making arrests and prosecutions for possession or use a low priority for law enforcement. |
| Therapeutic benefits | Research suggests that psychedelic mushrooms may have therapeutic benefits in treating conditions such as addiction, depression, anxiety, PTSD, and other mental health disorders. |
| Advocacy for reform | There are advocacy groups in Michigan pushing for reform and decriminalization of psychedelic mushrooms, citing their therapeutic potential and the need to reduce legal consequences for users. |
| Federal law | Under federal law, psychedelic mushrooms are illegal and classified as a Schedule I substance with no recognized medicinal value. However, there is ongoing research and a growing movement for decriminalization across the United States. |
Explore related products
What You'll Learn
- As of March 2025, psilocybin is a Schedule I controlled substance in Michigan
- Some Michigan cities have decriminalised psychedelic plants and fungi
- Psychedelics may have therapeutic benefits for treating inflammation, addiction, depression and anxiety
- There are risks and potential negative effects associated with psychedelics
- Psychedelics reform legislation is being pursued in several states

As of March 2025, psilocybin is a Schedule I controlled substance in Michigan
Psilocybin is the psychoactive compound found in "magic mushrooms" or "shrooms," which have been used for centuries in both spiritual ceremonies and recreational settings due to their powerful hallucinogenic properties. In recent years, psilocybin has gained increasing attention for its potential therapeutic benefits in treating various mental and psychological disorders. These potential benefits have led to a growing movement to decriminalize or legalize psilocybin, not just in Michigan but across the United States.
While psilocybin remains illegal under Michigan law, several cities within the state have taken steps toward decriminalization. For example, Detroit passed Proposal E in 2021, with over 61% of voters supporting the measure to decriminalize entheogenic plants and fungi, including psilocybin mushrooms. Other cities in Michigan that have passed similar resolutions include Ann Arbor, Ferndale, and Hazel Park. Decriminalization means that while psilocybin remains illegal, it becomes the lowest priority for law enforcement, and arrests and prosecutions for possession or use are less likely to occur.
Advocacy groups in Michigan are pushing for reform and statewide decriminalization. They argue that legalizing psilocybin in a medical setting and decriminalizing it can reduce the risks and costs associated with people using these substances. Additionally, they highlight the therapeutic potential of psilocybin in treating conditions such as addiction, depression, anxiety, and PTSD. However, it is important to note that the legalization and decriminalization of substances are two different things. Legalization allows businesses to produce and sell the product, while decriminalization prevents law enforcement from prioritizing arrests for possession or use.
As of March 2025, the use, possession, and sale of psilocybin in Michigan are still illegal, and it remains a Schedule I controlled substance. However, with the growing movement for psychedelic reform and the potential therapeutic benefits of psilocybin, the legal status of psilocybin in Michigan may continue to evolve in the future.
Should You Remove Stems from Shiitake Mushrooms?
You may want to see also

Some Michigan cities have decriminalised psychedelic plants and fungi
As of March 2025, psilocybin, the psychedelic compound found in "magic mushrooms", remains a Schedule I controlled substance under Michigan law, making its use, possession, or sale illegal. However, several Michigan cities have taken steps to decriminalize psychedelic plants and fungi, including psilocybin mushrooms.
Detroit, for example, passed Proposal E in 2021 with over 61% of voters supporting the measure to decriminalize entheogenic plants and fungi. This move was followed by other Michigan cities, including Ann Arbor, Ferndale, and Hazel Park, which have passed similar resolutions. Decriminalization means that while psilocybin remains illegal, it becomes the lowest law enforcement priority, and arrests and prosecutions for possession or use are deprioritized.
Ypsilanti stands out from other Michigan cities in its approach to decriminalizing psychedelic drugs. While other cities have passed resolutions to deprioritize enforcement of psychedelic-related activities, Ypsilanti's resolution explicitly prohibits the use of city funds or resources for investigating or prosecuting cases involving entheogenic plants.
Advocacy groups in the state are pushing for reform, and there are ongoing efforts to decriminalize psilocybin in Michigan, led by organizations like Decriminalize Nature Michigan. These groups focus on decriminalizing psychedelics by pushing for changes in local policies and raising awareness about their therapeutic potential.
The movement to decriminalize psychedelics in Michigan is driven by the potential therapeutic benefits of these substances. Scientists and wellness companies worldwide are studying the therapeutic effects of psychedelic plants and fungi in treating inflammation, addiction, depression, anxiety, PTSD, and other conditions. While critics have expressed concerns about fewer penalties leading to increased drug use and crime, decriminalization advocates cite research suggesting that psilocybin is non-addictive and causes fewer emergency visits compared to other illegal drugs.
Mellow Mushroom Charleston: Do They Deliver?
You may want to see also

Psychedelics may have therapeutic benefits for treating inflammation, addiction, depression and anxiety
In Michigan, psilocybin, the psychedelic ingredient in magic mushrooms, remains a Schedule I controlled substance under state law, making its use, possession, or sale illegal. However, several cities in the state, including Detroit, Ann Arbor, Ferndale, and Hazel Park, have passed resolutions to decriminalize entheogenic plants and fungi, including psilocybin mushrooms. This means that while psilocybin remains illegal, its enforcement becomes the lowest priority for law enforcement, and arrests and prosecutions for possession or use are deprioritized.
Amid the ongoing conversation around psychedelic reform in Michigan, there is also growing interest in the therapeutic benefits of psychedelics. Psychedelics have emerged as potential treatments for various mental health conditions, including depression, anxiety disorders, and drug addiction. Recent studies suggest that psychedelics can promote neuroplasticity by activating 5-HT2A receptors within brain cells, leading to the growth of new connections between neurons. This understanding of the mechanisms behind psychedelics' effects could inform the development of related drugs that encourage neuroplasticity without causing hallucinogenic side effects.
Additionally, psychedelics have shown promise in treating inflammation. Activation of 5-HT2A receptors has been found to produce potent anti-inflammatory effects in animal models of human inflammatory disorders. This discovery highlights the potential of psychedelics as novel anti-inflammatory agents, providing a new approach to treating inflammatory conditions.
Furthermore, psychedelics have been investigated for their therapeutic potential in treating addiction and withdrawal symptoms. For example, LSD has been studied as a treatment for alcoholism, opioid addiction, and anxiety and depression associated with terminal illness. Ayahuasca, a natural psychedelic brew rich in DMT and harmine, has also been found to induce subjective well-being and may possess antidepressant properties. These findings suggest that psychedelics could play a role in addiction recovery and improve mental health outcomes for individuals with substance use disorders.
While the therapeutic benefits of psychedelics are gaining recognition, it is important to approach their use with caution and under professional supervision. Further research and clinical trials are needed to fully understand the effects of psychedelics and develop safe and effective treatments.
Cremini Mushrooms: Are They a Good Source of Fiber?
You may want to see also
Explore related products

There are risks and potential negative effects associated with psychedelics
As of October 2024, psilocybin mushrooms are illegal in Michigan for personal use or purchase. However, several cities in Michigan, including Ann Arbor, Ferndale, Hazel Park, and Detroit, have decriminalized entheogenic plants and fungi, including psilocybin mushrooms. This means that while psilocybin remains illegal, its enforcement becomes the lowest priority for law enforcement, and arrests and prosecutions for possession or use are deprioritized.
One potential adverse effect of psychedelics is a "bad trip" or a "challenging experience," which can involve feelings of fear, anxiety, dysphoria, and paranoia. These experiences are usually short-lived but can be intense and distressing. Another possible risk is the development of hallucinogen-induced persistent perception disorder (HPPD), which can cause flashbacks and hallucinations even after the effects of the drug have worn off. In some cases, the long-term effects of using dissociative drugs may include suicidal thoughts.
Psychedelics can also interact with other drugs, increasing the risk of adverse effects and potential overdose. For example, there have been reports of fatalities after using mushrooms, but these cases typically involve the use of other dangerous drugs in combination with psychedelics. While there are no documented cases of overdose from psychedelics alone, it is important to recognize the potential risks associated with their use.
It is worth noting that the characterization of psychedelics as highly addictive is based on misinformation and misunderstanding. Studies have shown that psychedelics have a substantially lower potential for abuse and compulsive patterns of use compared to other substances. Additionally, the ritual use of certain psychedelics has not been associated with the negative psychosocial effects caused by other drugs of abuse.
Magic Mushrooms: Mind-Altering Transformations
You may want to see also

Psychedelics reform legislation is being pursued in several states
As of 2025, psychedelic mushrooms are illegal in Michigan, classified as a Schedule I controlled substance under Michigan law. However, there is a growing movement for psychedelic reform across the state and the US.
In March 2022, Colorado activists selected a psychedelic reform initiative (Proposition 122) to be placed on the state's 2022 election ballot. The ballot initiative passed with over 50% of the vote, decriminalizing the possession, growing, and sharing of five psychedelics (psilocybin, psilocin, DMT, ibogaine, and mescaline) for personal use for those aged 21 and over. Colorado is now establishing a state-regulated program for psychedelic mushrooms, following in the footsteps of Oregon, which was the first state to decriminalize possession and provide clinical psilocybin services. Oregon's legislation includes extensive guidelines on psilocybin production, manufacturing requirements, mandatory testing of purity and potency, record-keeping, and facilitator qualifications.
In Michigan, several cities, including Ann Arbor, Ferndale, Hazel Park, and Detroit, have passed resolutions to decriminalize entheogenic plants and fungi, making their enforcement the lowest priority for law enforcement. This means that arrests and prosecutions for possession or use are deprioritized. Ypsilanti has gone a step further by explicitly prohibiting the use of city funds or resources for investigating or prosecuting cases involving entheogenic plants.
On the state level, lawmakers in eleven states pursued psychedelics reform legislation for the 2023 session. While a bill to decriminalize the possession and use of small amounts of psilocybin and other psychedelics for adults aged 21 and over passed the California Senate, it was vetoed by Governor Gavin Newsom, who urged the legislature to include therapeutic guidelines. In New Mexico, the governor signed a bill to establish a therapeutic psilocybin program, and similar legislative efforts have been made in Iowa and Vermont.
As scientific research on the therapeutic and medicinal potential of psychedelics grows, so does legal and political support. An analytic model based on marijuana legalization projects that a majority of states will legalize psychedelics by 2033-2037. However, the future of psychedelics in the United States also depends on factors such as FDA decisions on clinical trials and potential changes to the DEA's classification of psychedelics.
Truffle Labeling: A Step-by-Step Guide for Mushroom Lovers
You may want to see also
Frequently asked questions
As of October 2024, psilocybin mushrooms are illegal in Michigan for personal use or purchase. However, some cities in Michigan, including Detroit, Ann Arbor, Ferndale, and Hazel Park, have decriminalized psychedelic mushrooms.
Decriminalization means that while psilocybin remains illegal, it becomes the lowest priority for law enforcement, meaning arrests and prosecutions for possession or use are less likely to occur.
Psilocybin mushrooms have been found to have potential therapeutic benefits, including the treatment of addictions, depression, anxiety, PTSD, migraines, and other mental and psychological disorders.

























